Trial Details

COMPLETED
Basic Information
Clinical ID c688
Identifier NCT06221111
Trial Title Comparison of Rimegepant and Placebo for Pain in IBS
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: Rimegepant 75 MG [Nurtec]
Participant Information
Sponsor Mayo Clinic
City Rochester
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2024-06-06
Primary Completion Date 2025-05-30
Completion Date 2025-06-03